Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 783.76B | 797.13B | 795.27B | 851.96B | 733.01B | 551.29B |
Gross Profit | 281.55B | 294.93B | 266.30B | 325.41B | 295.63B | 201.96B |
EBITDA | 205.00B | 243.19B | 190.92B | 240.55B | 230.32B | 157.62B |
Net Income | 137.60B | 147.56B | 133.16B | 170.59B | 155.27B | 94.01B |
Balance Sheet | ||||||
Total Assets | 1.92T | 1.94T | 1.93T | 1.87T | 1.78T | 1.63T |
Cash, Cash Equivalents and Short-Term Investments | 579.05B | 606.50B | 539.08B | 529.23B | 601.22B | 586.78B |
Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities | 212.44B | 197.14B | 206.84B | 245.98B | 234.09B | 189.64B |
Stockholders Equity | 1.69T | 1.72T | 1.71T | 1.62T | 1.54T | 1.43T |
Cash Flow | ||||||
Free Cash Flow | 33.80B | 214.47B | 117.88B | 52.44B | 91.22B | 96.23B |
Operating Cash Flow | 48.28B | 255.27B | 171.76B | 99.50B | 125.58B | 118.00B |
Investing Cash Flow | 10.10B | -134.08B | -13.56B | -78.00B | -53.93B | -16.77B |
Financing Cash Flow | -33.41B | -136.62B | -122.51B | -127.92B | -89.15B | -53.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $11.16T | 12.12 | 10.17% | 3.48% | -4.85% | 2.78% | |
79 Outperform | ¥4.47T | 10.12 | 4.43% | 5.97% | 13.80% | ||
79 Outperform | $18.80T | 30.74 | 10.50% | 1.07% | 0.56% | 5.36% | |
77 Outperform | ¥5.16T | 28.88 | 8.97% | 0.74% | -1.55% | 17.21% | |
76 Outperform | ¥6.45T | 19.71 | 8.40% | 1.96% | 5.02% | 14.73% | |
73 Outperform | ¥3.45T | 23.74 | 2.61% | 0.23% | 12.16% | ||
61 Neutral | C$6.63B | 7.56 | 3.42% | 2.77% | 6.63% | -23.02% |